Nov 04, 2016
1:30
For every 30 shares held, investors received 1. The price per share adjusted from $0.49 to $0.02.
The split itself did not change the total investment value.
Albireo Pharma, Inc. (ALBO) trades on the NASDAQ Capital Market in the Biotechnology industry.
Albireo Pharma, Inc. company overviewThe latest split shown was on November 4, 2016. It was a 1-for-30 reverse split, so shareholders received 1 share for every 30 they held.
This history records 2 reverse splits between June 12, 2012 and November 4, 2016.